Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office
Long Arm Engineering将在德克萨斯州敖德萨工厂和新公司办公室实施适合值班筛查的安全进入
TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating deployment of Safe Entry to be deployed at LongArm Engineering's Odessa Texas facility, secured by the Company's lead reseller, SBL Testing Technologies.
多伦多，on/ACCESSWIRE/2022年11月17日/由专有人工智能(AI)支持的快速健康筛查解决方案的新兴提供商Predicmedix Inc.(CSE：PMED)(场外交易市场代码：PMEDF)(以下简称“Predidicmedix”或“公司”)今天宣布，将在Long Arm Engineering的德克萨斯州敖德萨工厂部署安全进入系统，该系统将由该公司的主要经销商SBL Testing Technologies担保。
LongArm Engineering will be implementing Safe Entry at their Odessa Texas facility, a full cycle operation including engineering, electrical, automation, and fabrication. Odessa Texas is in the heart of the Permian Basin, currently one of the largest and most active oil & gas basin hotspots. Safe Entry will be used to screen staff, contractors, clients, and guests to ensure a healthy and safe workplace.
Long Arm Engineering将在其德克萨斯州敖德萨工厂实施安全进入，这是一个包括工程、电气、自动化和制造在内的全周期运营。德克萨斯州敖德萨位于二叠纪盆地的中心，目前是最大和最活跃的油气盆地热点之一。安全进入将用于对工作人员、承包商、客户和客人进行筛选，以确保工作场所的健康和安全。
"We see Safe Entry as a tool to maintain a safe workplace amongst our employees, contractors, and clients as they enter our facility. This will ensure prevention of spread of any infectious disease to others and keep our company strong. Our employees are critical to our business and see this as a commitment to their health. Alcohol and Cannabis screening will show we are dedicated to performing our services in a professional environment," said Aaron Young, Managing Partner of LongArm Engineering.
Long Arm Engineering管理合伙人Aaron Young表示：“我们将安全入境视为员工、承包商和客户进入我们工厂时维护安全工作场所的一种工具。这将确保防止任何传染病传播给其他人，并保持我们公司的强大。我们的员工对我们的业务至关重要，并将此视为对他们健康的承诺。酒精和大麻筛查将表明我们致力于在专业环境中提供服务，”Long Arm Engineering的管理合伙人Aaron Young表示。
"We are seeing increasing demand for Safe Entry. Businesses and organizations in all market verticals are strengthening their pandemic response strategies. Safe Entry is very differentiated and unique in detecting multiple symptoms of infectious diseases, all on a continuously learning AI platform. It's a key technology within long-term strategies." stated Rich Rollibard from SBL Testing Technologies.
我们看到对安全进入的需求越来越大。所有垂直市场的企业和组织都在加强他们的流行病应对战略。安全进入在检测传染病的多种症状方面非常差异化和独特，所有这些都是在一个持续学习的人工智能平台上。这是长期战略中的一项关键技术。来自SBL测试技术公司的Rich Rollibard说。
"The global interest in supplying Safe Entry is also increasing. SBL is on-boarding partner companies to supply and support Safe Entry in all regions of the world." Robillard added. "The evolution of Safe Entry technology has been eye opening, and now being able to screen for not only infectious diseases but simultaneously alcohol and cannabis use, is a huge feat. We are excited to see the positive impact it will have on LongArm Engineering's workforce," said Dr. Rahul Kushwah, Interim CEO at Predictmedix.
全球对提供安全入境的兴趣也在增加。SBL正在与合作伙伴公司合作，在世界所有地区提供和支持安全入境。罗比拉德补充道。Predidicmedix公司临时首席执行官拉胡尔·库什瓦博士表示：“安全进入技术的发展令人大开眼界，现在不仅能够筛查传染病，还能同时筛查酒精和大麻的使用，这是一项巨大的壮举。我们很高兴看到它将对长臂工程公司的员工队伍产生积极影响。”
About LongArm Engineering
LongArm Engineering is one of the Permian Basins' fastest growing full-service automation and electrical firms, with services ranging from well site servicing to major construction projects. To learn more about LongArm Engineering, please click here.
关于长臂工程
Long Arm Engineering是二叠纪盆地增长最快的全方位自动化和电气公司之一，服务范围从油井现场服务到重大建设项目。要了解更多有关长臂工程的信息，请单击此处。
About SBL Testing Technologies Inc.
SBL integrates innovative safety & testing technologies into complex workplaces, aligning to corporate risk profiles, safety programs and operational processes. SBL works with businesses, government agencies, and organizations in all industrial sectors globally, leveraging technology to reduce risk and enhance policy effectiveness. SBL's team has successfully provided risk management, safety solutions and testing technologies for decades, working with leading technology manufacturers from around the globe. SBL's Pandemic Response / Business Continuity solutions are led by a team who have successfully delivered fully integrated solutions to government agencies & Fortune 500 companies worldwide. For more information visit us online at
关于SBL测试技术公司
SBL将创新的安全和测试技术集成到复杂的工作场所，与企业风险概况、安全计划和运营流程保持一致。SBL与全球所有工业部门的企业、政府机构和组织合作，利用技术降低风险并提高政策有效性。几十年来，SBL的团队与全球领先的技术制造商合作，成功地提供了风险管理、安全解决方案和测试技术。SBL的大流行应对/业务连续性解决方案由一支成功地向全球政府机构和财富500强公司提供全面集成解决方案的团队领导。欲了解更多信息，请访问我们的在线网站
About Predictmedix Inc.
Predictmedix (CSE:PMED) (OTCQB:PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatique or various mental illnesses. Predictmedix's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at or follow us on Twitter, Instagram or LinkedIn.
关于Predicate Medix Inc.
普瑞医疗(CSE：PMED)(场外市场代码：PMEDF)是一家新兴的全球快速健康筛查和远程患者护理解决方案提供商。该公司的安全入口站由专有人工智能(AI)提供支持，使用多光谱相机分析生理数据模式并预测各种健康问题，包括传染病(如新冠肺炎)、药物或酒精损害、疲劳或各种精神疾病。PredidicMedix专有的远程患者护理平台为医疗专业人员提供了一套人工智能支持的工具，以改善患者的健康状况。要了解更多信息，请访问我们的网站，或在Twitter、Instagram或LinkedIn上关注我们。
Investor Relations Contact
Corey Matthews
Investors@predictmedix.com
投资者关系联系人
科里·马修斯
邮箱：Investors@forectmedix.com
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.
有关前瞻性信息的警告：
本新闻稿可能包含基于当前预期的前瞻性陈述和信息。这些声明不应被解读为对公司未来业绩或结果的保证。这类陈述涉及已知和未知的风险、不确定因素和其他因素，可能导致实际结果、业绩或成就与这类陈述所暗示的大不相同。虽然这些陈述是基于管理层的合理假设，但不能保证这些假设将被证明是正确的。我们不承担更新或修改它们以反映新事件或新情况的责任。本公司的证券尚未根据修订后的《1933年美国证券法》(下称《美国证券法》)或适用的州证券法进行注册，除非进行注册或获得适用的豁免，否则不得向美国境内的人或美国人提供或出售，或为美国境内的人或“美国人”的账户或为他们的利益服务。本新闻稿不应构成出售要约或征求购买要约，也不应在美国或任何司法管辖区出售任何此类要约、征求或出售将是非法的证券。此外，存在已知和未知的风险因素，可能导致公司的实际结果、业绩或成就与本文中包含的前瞻性信息明示或暗示的未来结果、业绩或成就的第4页存在实质性差异，例如但不限于对获得监管部门批准的依赖；获得与其技术相关的知识产权的能力；有限的经营历史；一般商业、经济、竞争、政治、监管和社会方面的不确定性，尤其是, 与新冠肺炎有关的不确定性；与公司无法控制的因素有关的风险，包括与新冠肺炎有关的风险；与公司股票有关的风险，包括因可能或可能不在公司控制范围内的事件而引起的价格波动；对管理层的依赖；以及行业中更多竞争对手的紧急情况。
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
本文中的所有前瞻性信息都受本警示声明的约束，公司没有义务修改或更新任何此类前瞻性信息，也没有义务公开宣布对本文中包含的任何前瞻性信息的任何修改结果，以反映未来的结果、事件或发展，除非法律要求。
Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time."
免责声明：“本公司目前不会明示或暗示其产品有能力诊断、消除、治愈或控制新冠肺炎(或SARS-2冠状病毒)。”
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
加拿大证券交易所尚未对本新闻稿的充分性或准确性进行审查，也不承担任何责任。
SOURCE: PredictMedix Inc.
资料来源：PredidicMedex Inc.
译文内容由第三方软件翻译。